|


After consultation with, and
comprehensive evaluation by, a sleep specialist, each patient is diagnosed and appropriate
therapy is determined. As part of the consultation and evaluation, a sleep study may be
performed during a period of one or two nights. Hospitalization is not required; overnight
tests are completed by 7 am. During a sleep study, the patient is monitored by painless,
noninvasive technology.
A sleep test
(polysomnogram) simultaneously records heart rate, brain waves, breathing, oxygenation,
and eye and leg movement. Treatment for a sleep disorder may include a prescription for a
device to aid the patient's breathing while sleeping, medication, or light therapy as well
as neuropsychiatric interventions, including biofeedback. If indicated, referral to or
consultations with other specialists might be recommended to aid in diagnosis and
treatment.


The staff of the Sleep Disorders Center
(three attending physicians and three study coordinators), under the direction of Dr.
Karetzky, has been conducting research and clinical trials for over 25 years in sleep
medicine, pulmonary medicine, critical care medicine, internal medicine, and nutritional
support. Pharmaceutical-company-sponsored
Phase I, II, III, and IV clinical trials have been and are taking place in the following
areas: narcolepsy, obstructive sleep apnea, insomnia, chronic obstructive pulmonary disease, asthma,
adult respiratory distress syndrome, pneumonia, bronchitis, heart failure, sepsis, bacteremia, candidemia, and sinusitis.
Other areas
of investigation include, chronic fatigue syndrome, insomnia with obesity, obesity, pulmonary embolisms, cardiopulmonary diagnostic
exercise, pancreatitis, and rhinitis.
For further
information on current research and clinical trials, please contact the
center.
| |
Current
Clinical Trial |
|
| |

The Newark Sleep Disorders Center is recruiting
participants for a clinical trial of a new medication for the treatment of
insomnia, specifically for those who wake up in the middle of the night and
have difficulty falling back to sleep.
The effects of the medication will be compared with those of a placebo in a
double-blind randomized study. Participants will be required to visit the
center five times over six to eight weeks. Overnight monitoring is not
required.
Requirements: Participants must be in good health, be between the ages of 18
and 64, and the insomnia must have pre-existed for at least three months.
Those taking part may be paid for their participation.
To determine eligibility or for more information, please contact Medesta
Rembert or Dr. Li at 973-926-8204 or
email
the center. |
|
|